Recently, Shanghai Phoebus Medical Co. Ltd. ("Phoebus Medical"), a healthcare management company specialized in utilizing AI technology to manage chronic diseases, officially announced the completion of its series A financing. The lead investor for this round of financing is Cenova Capital; and United Capital, Songjiang SHIVC are co-investors.
Phoebus Medical is driven by the idea of providing innovative medical services with precise big data. Aiming to provide better healthcare management services to diabetes patients, Phoebus Medical uses big data from monitoring diabetic retinopathies to facilitate collaboration among medical institutions. In addition, big data could enhance medical institutions' capability in diabetic care from difference aspects, including academic development, patient management, and clinical practices.
As the legal counsel of Phoebus Medical, Llinks provided legal services for its series A financing.
